
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Prepared to a prescriber's order for one patient. Not FDA-approved.
This is a compounded topical gel containing methyl salicylate, prepared to a prescriber's order for one patient. Compounded preparations are not FDA-approved.
These listings cover every salt or ester form of each drug in the FDA National Drug Code Directory.
FDA-approved products contain methyl salicylate only in combination with other active ingredients, in patch form. It is also a component of FDA-approved kits.
Gel bases can be aqueous or nonaqueous, and USP <795> classifies the preparation by its water activity. Aqueous preparations carry shorter default beyond-use dates than nonaqueous ones. The date printed on the label is the one to follow.
Compounded drugs are not FDA-approved. This means that FDA does not review these drugs to evaluate their safety, effectiveness, or quality before they reach patients.
Methyl salicylate, also called oil of wintergreen, is a topical counterirritant pain reliever that a pharmacy may compound when a prescriber orders it.
Methyl salicylate is a salicylate, related to aspirin, that smells of wintergreen. On the skin it acts as a counterirritant. It is an ingredient in deep-heating creams and other over-the-counter products for sore muscles and joints. Thera-Gesic cream lists methyl salicylate as a counterirritant for temporary relief of minor aches and pains of muscles and joints associated with arthritis, simple backache, strains, bruises and sprains. Salonpas Pain Relief Patch, which combines methyl salicylate with menthol, is FDA-approved for temporary relief of mild to moderate aches and pains of muscles and joints. A prescriber might order methyl salicylate compounded in a strength, vehicle or combination that is not manufactured. Compounded preparations are not FDA-approved and require a prescription.
Methyl salicylate is for external use only. Product labels say not to use it on wounds or damaged skin, right after a bath or shower, with a heating pad, or under a bandage or wrap, and not to use it if you are sensitive to oil of wintergreen or allergic to aspirin or other NSAIDs. The Salonpas label carries an NSAID stomach bleeding warning, says to ask a doctor first if you take a diuretic or a blood thinner, or have high blood pressure, heart disease or kidney disease, and says not to use it at 20 weeks or later in pregnancy unless a doctor directs. Swallowing it is dangerous: MedlinePlus calls methyl salicylate the most poisonous form of salicylate, and keep products away from children. Stop and ask a doctor if irritation develops or pain persists. Talk to your prescriber or pharmacist about side effects.
Methyl salicylate is a salicylate used topically as a counterirritant; it can be absorbed through intact skin, and case reports describe salicylate poisoning after ingestion, application to abnormal skin, or inappropriate application to normal skin, though systemic toxicity is rare with appropriate use. Salicylate toxicity presents with tinnitus, hyperpnea, tachypnea, high fever, diaphoresis and mixed acid-base disturbances. Labeled OTC uses: temporary relief of minor aches and pains of muscles and joints (Thera-Gesic cream, methyl salicylate with menthol); temporary relief of mild to moderate muscle and joint pain in adults (Salonpas Pain Relief Patch, approved under an NDA, which the label treats as an NSAID). Salonpas warnings include stomach bleeding risk with age 60 or older, prior ulcers, anticoagulants, steroids or other NSAIDs; avoidance right before or after heart surgery; and possible increased risk of heart attack or stroke if used more or longer than directed. Thera-Gesic advises asking a doctor before use in children under 12. Dosing is per prescriber. Counsel against heat, occlusion and use on broken skin.
Wash your hands. Apply the amount on your label to clean, dry skin and spread it in a thin layer. For a metered pump, your label states the number of presses. For a dosing syringe, push the plunger to the mark. Let the gel dry before covering with clothing. Wash your hands afterward and keep the site from touching other people until it has dried. Do not apply to broken skin unless told to.
A gel can have a nonaqueous or a water-based base, and USP <795> sets its default beyond-use date by water content, not by the word gel. A nonaqueous gel usually carries a beyond-use date of up to 180 days at room temperature or refrigerated. A water-based gel carries up to 35 days with a preservative, or 14 days refrigerated without one. Your label states which applies. Keep the container closed, away from heat and open flame if it contains alcohol, out of reach of children, and discard after the beyond-use date on your label.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Apply topically to affected area(s)